Traders Cafe with Zak Mir: Dev Clever (DEV), Quantum Blockchain (QBT), Supply@Me Capital (SYME), Tiziana (TILS), Xtract (XTR), Wishbone Gold (WSBN)
It is sometimes the case that “non-news” has as much as, or even more impact that significant newsflow. We were reminded of this in the case of (QBT). The company formerly known as Clear Leisure, has remodelled its strategy to go for investment in cryptocurrencies. Ideally, its chosen assets class manages to keep its head above water until QBT is ready to embark on this goal. In the meantime, the Sipiem hearing regarding the final assessment of the economic merit of the claim against its previous management and internal audit committee at the Court of Venice has been pushed back a day to May 27. Shares of Quantum Blockchain rallied 0.25p to 1.97p.
There was a solid 13% rebound for shares of Edtech specialist (DEV), as the company which has flourished in the wake of the pandemic returned to favour. Recent weeks have seen the stock caught in the crossfire of the margin issues of certain traders, but it would appear that this has finally worked its way out of the system. In March Dev shares bounced at 23p to hit a 39.5p. For May we have seen a low of 22.1p and a bear trap below that old support. Last month the leading developer of mobile and immersive experiences, said that it has entered into a comprehensive agreement with Veative Labs. This involved acquiring the entire issued share capital of Veative Labs Private Limited, a wholly owned Indian subsidiary of Veative and the publication of a prospectus.
There was fresh news from copper-gold specialist (XTR) as it continues its campaign with regard to the Bushranger Project. The company said the assay results from the first three holes of the Phase One drilling programme at the Racecourse Prospect have succeeded in extending the copper mineralisation 350-450m to the northwest of the current limit of the Mineral Resource and a significant distance down dip. In comparison to previous drilling on the project by Anglo American, our recent intersections are substantially wider, suggesting that as the Racecourse mineralisation extends to the northwest it is growing significantly in thickness.
There was a second consecutive day of significant newsflow for biotech group (TILS) and a further rebound for the stock to 86p, from below 70p last week. The latest driver was an update on further analysis of lymphocyte subsets from blood samples from a Phase 1 study with nasally administered Foralumab in healthy volunteers. Results exhibiting statistically significant immunomodulatory effects on CD8 cytotoxic T-lymphocytes and other inflammatory biomarkers were observed. Tiziana said it intends to make further tests on MS patients.
The recent bull run at gold explorer (WSBN) continued apace, as the Australia focused company announced that Dr Simon Beams, the MD and Principal Geologist of Terra Search, will be presenting Wishbone's Halo Gold/Copper Project to an Australasian Institute of Mining and Metallurgy Conference on May 27th. The stock has been on the front foot since last week’s announcement of a premium placing at 14p to raised £1.4m. The shares have so far peaked at 19.5p.
Shares of working capital provider (SYME) continued their recent stabilisation on the latest news from the company. SYME, which remains very much the punters favourite, said it has signed a Share Purchase Agreement to acquire the entire issued share capital of TradeFlow Capital Management. The acquisition will enable SYME to further enhance its Platform, delivering a global inventory monetisation service.
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.